Institutional investors hold a majority ownership of JNJ through the 68.39% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MANAGED ACCOUNT ADVISORS LLC Bought 3.7 Million shares of Johnson & Johnson
APG ASSET MANAGEMENT NV Bought 2.3 Million shares of Johnson & Johnson
NATIXIS ASSET MANAGEMENT SA Bought 2.1 Million shares of Johnson & Johnson